Trials / Completed
CompletedNCT06173856
Effectiveness of Phototherapy With and Without Probiotics
Effectiveness of Phototherapy With and Without Probiotics for the Treatment of Indirect Hyperbilirubinemia in Preterm Neonates
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Fatima Jinnah Medical University · Academic / Other
- Sex
- All
- Age
- 0 Hours – 1 Week
- Healthy volunteers
- Not accepted
Summary
Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The standard treatment for neonatal jaundice is phototherapy but probiotics along with it can reduce the duration of phototherapy and hospitalization stay, secondarily can reduce the risk of nosocomial infection.
Detailed description
Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The comparative analytical study was conducted after the ethical approval for one year (Jan 2022-Jan 2023) in the neonatal unit of The University of Lahore Teaching Hospital, Lahore, Pakistan. 76 preterm neonates fulfilling the selection criteria were included in the study and divided into two groups. Standard phototherapy was applied in both groups and group A probiotic (Saccharomyces boulardii) 125mg, twice daily, orally (in 5cc of milk whichever the baby was taking) was given till discharge from the hospital. The primary outcome measurements were the duration of phototherapy and the length of hospitalization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LED phototherapy | LED phototherapy (430-470nm) alone will be applied. |
Timeline
- Start date
- 2022-01-10
- Primary completion
- 2022-10-10
- Completion
- 2023-01-15
- First posted
- 2023-12-18
- Last updated
- 2023-12-18
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06173856. Inclusion in this directory is not an endorsement.